| For: | Finnerty BM, Gray KD, Moore MD, Zarnegar R, Fahey III TJ. Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective. World J Gastrointest Oncol 2017; 9(9): 341-353 [PMID: 28979716 DOI: 10.4251/wjgo.v9.i9.341] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i9/341.htm |
| Number | Citing Articles |
| 1 |
Jon Arne Søreide, Jan Terje Kvaløy, Dordi Lea, Oddvar M. Sandvik, Mohammed Al‐Saiddi, Torjan M. Haslerud, Herish Garresori, Lars N. Karlsen, Einar Gudlaugsson, Kjetil Søreide. The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study. Cancer Reports 2022; 5(2) doi: 10.1002/cnr2.1462
|
| 2 |
Fang Guo, Yun-Zhi Chen, Liu Li, Cong Chen, Jian-Hua Jin, Jie Yang, Jing-Jing Chen, Xin-Yan Chen, Min Guo, Yu-Mei Chen. Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis. Biomedicine & Pharmacotherapy 2018; 98 doi: 10.1016/j.biopha.2017.11.143
|
| 3 |
Mariola Winiarek, Malgorzata Malinowska, Piotr Saramak, Marek Szpakowski, Tomasz Olesiński. Renal cell carcinoma metastasis to neuroendocrine pancreas tumor: case report and literature review. Chirurgia 2019; 32(4) doi: 10.23736/S0394-9508.18.04852-0
|
| 4 |
M.J. Klomp, S.U. Dalm, M. de Jong, R.A. Feelders, J. Hofland, L.J. Hofland. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer. Reviews in Endocrine and Metabolic Disorders 2021; 22(3) doi: 10.1007/s11154-020-09607-z
|
| 5 |
А. Маркович, A. Markovich, С. Ширяев, S. Shiryaev, М. Гончаров, M. Goncharov, А. Крылов, A. Krylov, Д. Комановская, D. Komanovskaya, А. Рыжков, A. Ryzhkov. Evaluating the Effectiveness of Somatostatin Receptors Scintigraphy with 111In-Octreotide in the Diagnosis of Neuroendocrine Tumors. Medical Radiology and radiation safety 2018; doi: 10.12737/article_5b179a86bf0387.39000853
|
| 6 |
Katerina Zakka, Rebecca Nagy, Leylah Drusbosky, Mehmet Akce, Christina Wu, Olatunji B. Alese, Bassel F. El-Rayes, Pashtoon Murtaza Kasi, Kabir Mody, Jason Starr, Walid L. Shaib. Blood-based next-generation sequencing analysis of neuroendocrine neoplasms. Oncotarget 2020; 11(19) doi: 10.18632/oncotarget.27588
|
| 7 |
James Y. Lim, Rodney F. Pommier. Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.622693
|
| 8 |
Rupali Sharma, Bhargav Earla, Kwamena E. Baidoo, Martha A. Zeiger, James P. Madigan, Freddy E. Escorcia, Samira M. Sadowski. Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model. Molecular Cancer Therapeutics 2023; 22(9) doi: 10.1158/1535-7163.MCT-22-0798
|
| 9 |
Benjamin C. Greenspun, Amanda Foshag, Abhinay Tumati, Teagan Marshall, Dongxiang Xue, Liuliu Yang, Shuibing Chen, Rasa Zarnegar, Thomas J. Fahey, Brendan M. Finnerty. DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection. Surgery 2025; 177 doi: 10.1016/j.surg.2024.06.064
|
| 10 |
Simone Donati, Simone Ciuffi, Francesca Marini, Gaia Palmini, Francesca Miglietta, Cinzia Aurilia, Maria Luisa Brandi. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome. International Journal of Molecular Sciences 2020; 21(20) doi: 10.3390/ijms21207592
|
| 11 |
P. Vladova. MODERN PATHOLOGICAL CONSTELLATION FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS AND IMMUNOHISTOCHEMICAL PANEL. Trakia Journal of Sciences 2022; 20(4) doi: 10.15547/tjs.2022.04.010
|
| 12 |
Fabrice Viol, Bence Sipos, Martina Fahl, Till S. Clauditz, Tania Amin, Malte Kriegs, Maike Nieser, Jakob R. Izbicki, Samuel Huber, Ansgar W. Lohse, Jörg Schrader. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. Cellular Oncology 2022; 45(6) doi: 10.1007/s13402-022-00727-z
|
| 13 |
Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Oberg, Irvin M. Modlin, Andrea Frilling. Neuroendocrine Neoplasms of the Small Bowel and Pancreas. Neuroendocrinology 2020; 110(6) doi: 10.1159/000503721
|
| 14 |
O. I. Kit, D. Yu. Gvaldin, V. S. Trifanov, E. N. Kolesnikov, N. N. Timoshkina. Molecular-Genetic Features of Pancreatic Neuroendocrine Tumors. Russian Journal of Genetics 2020; 56(2) doi: 10.1134/S1022795420020064
|
| 15 |
Guido Rindi, Bertram Wiedenmann. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nature Reviews Endocrinology 2020; 16(10) doi: 10.1038/s41574-020-0391-3
|
| 16 |
Rui Jiang, Xiafei Hong, Yupei Zhao, Wenming Wu. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms. Cancer Letters 2021; 499 doi: 10.1016/j.canlet.2020.11.012
|